Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY: CAH )

121.84 -1.58 (-1.28%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cardinal Health

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Peering Into Cardinal Health's Recent Short Interest
Via Benzinga
Why NYSE:CAH is a Top Pick for Dividend Investors.
Why the dividend investor may take a look at CARDINAL HEALTH INC (NYSE:CAH). 
Via Chartmill
Cardinal Health Stock Sees IBD RS Rating Improve To 71
In a welcome move, Cardinal Health stock saw its Relative Strength (RS) Rating rise from 65 to 71 on Friday. 
Via Investor's Business Daily
Tech Stocks Surge But S&P 500 Faces Second Weekly Decline, Amazon Rallies, Bitcoin Drops Below $70,000: What's Driving Markets Friday?
Wall Street rebounded Friday following Thursday’s selloff, yet midday gains were still insufficient to prevent a second consecutive weekly decline for the S&P 500, currently down 1% for the week. 
Via Benzinga
Topics Stocks
Exposures US Equities
Cardinal Health Q1 Earnings And Revenues Beat Estimates
Cardinal Health came out with quarterly earnings of $1.88 per share. 
Via Talk Markets
Earnings Outlook For Cardinal Health
Via Benzinga
Is NYSE:CAH suited for dividend investing?
Is CARDINAL HEALTH INC (NYSE:CAH) a Good Fit for Dividend Investing? 
Via Chartmill
Why NYSE:CAH provides a good dividend, while having solid fundamentals.
Why CARDINAL HEALTH INC (NYSE:CAH) is a Top Pick for Dividend Investors. 
Via Chartmill
Amazon Posts Upbeat Results, Joins Cardinal Health, Waters, Atlassian, Charter Communications, MasTec And Other Big Stocks Moving Higher On Friday
Via Benzinga
Cardinal Health Raises 2025 Profit Outlook Again, Helped By Strong Drug Distribution Business
Cardinal Health reported Q1 2025 EPS of $1.88, surpassing estimates. Pharmaceutical revenue declined but grew 16% excluding contract expirations. FY 2025 EPS guidance raised. 
Via Benzinga
US Stocks Likely To Open Higher After 'Mag 7' Wrap Up Busy Week, Apple, Amazon And Intel On Radar: Investors Eye Monthly Jobs Report, Economist Says Earnings Won't Trump Bonds
Investors on Wall Street could see some respite after major indices registered a downbeat session on Thursday. Index futures point to a positive start on Friday, ahead of the crucial monthly report on... 
Via Benzinga
Topics Government
Exposures Political
Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years
Via Benzinga
Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings
Via Benzinga
S&P 500 Records Worst Session In Over A Month, Meta And Microsoft Tumble: Greed Index Moves To 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Apple, Amazon And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Marjorie Taylor Greene Stays Loyal To Trump, Keeps DJT Stock, Buys Into Warren Buffett's Berkshire In Latest Trades
Marjorie Taylor Green's investment portfolio includes bets on technology, Warren Buffett and Donald Trump. 
Via Benzinga
Topics Government
Exposures Political
Cardinal Health, Inc. Dividend Stock Analysis
Cardinal Health Inc. is one of the leading wholesale distributors of pharmaceuticals, medical/surgical supplies and related products to a broad range of health care customers. 
Via Talk Markets
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives. 
Via Benzinga
Opioid Settlement: Drug Distributors McKesson, Cencora, Cardinal Health To Pay $300M To Health Insurers
Three major U.S. drug distributors, McKesson, Cencora, and Cardinal Health, have agreed to a $300 million settlement over claims by health insurers and benefit plans that they contributed to the opioid... 
Via Benzinga
Cardinal Health Stock Sees Relative Strength Rating Climb To 71
In a welcome move, Cardinal Health stock saw its Relative Strength Rating improve from 63 to 71 on Wednesday. 
Via Investor's Business Daily
How To Build A Dividend Growth Portfolio In An Overpriced Market
The stock market as measured by the S&P is currently at an all-time high which makes it very challenging to try to build a quality dividend growth portfolio. 
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Companies Reporting Remarkable Results: Walmart, Eli Lilly, Cardinal Health
Several companies have stolen the spotlight throughout the earnings period, including Walmart, Cardinal Health, and Eli Lilly. All three posted robust results and upped guidance, as shares of each... 
Via Talk Markets
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Wall Street Battles For Fifth Day Of Gains As Inflation Cools, Gives Green Light To Rate Cuts; Financials Outperform: What's Driving Markets Wednesday?
The July consumer inflation report released Wednesday confirmed a continued cooling trend in price increases across the economy, with the headline Consumer Price Index (CPI) coming in at 2.9%... 
Via Benzinga
Topics Economy
Exposures Economy Interest Rates
Stocks To Watch Today: Alphabet, Cardinal Health, And Kellanova
Alphabet faces a potential breakup by the DOJ, causing its shares to tumble; Cardinal Health rises on strong earnings and improved guidance; and Kellanova surges following news of its acquisition by... 
Via Talk Markets
CAH Stock Earnings: Cardinal Health Beats EPS, Beats Revenue for Q4 2024
CAH stock results show that Cardinal Health beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
S&P 500 Rises, Small Caps Outperform As July Consumer Price Index Fuels Fed Rate Cut Hopes: 5 ETFs to Watch Wednesday
US inflation eases in July, keeping Fed rate cut hopes alive. Stocks rise, yields stable, dollar gains against yen. Tech and small caps outperform. 
Via Benzinga
Topics ETFs Economy Stocks
Exposures Interest Rates US Equities
Cardinal Health Reports Double Beat In Fiscal Q4
Cardinal Health has reported impressive fourth-quarter and fiscal year 2024 results, surpassing market expectations. 
Via Talk Markets
Top 3 Health Care Stocks That May Crash In August
Via Benzinga
Cardinal Health Poised To Retake Key Level On Bullish Fiscal 2025 View
Cardinal Health reported better-than-expected fiscal fourth-quarter earnings and hiked 2025 profit expectations 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.